Home › Products › Diabetes › Poviztra 1mg FlexTouch
Poviztra 1mg FlexTouch
Salt Composition: SEMAGLUTIDE
- Manufacturer: ZUVENTUS HEALTHCARE LTD
- Pack Size: 1 PREFILLED PEN(s)
- Dosage Form: INJECTION
- Strength: 1MG
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Store your pen in the fridge (not the freezer) it should be kept between 2°C and 8°C. If you forget a dose, take it within 5 days. If itâs been longer, skip that dose and stick to your regular schedule. Never take two doses at once to make up for a missed one. Signs of overdose (like severe nausea or vomiting) need medical attention right away. Always keep the pen out of childrenâs reach and donât share it, even if the needle is changed.
₹9408.00₹11200.00
Inclusive of all taxes
Product Introduction
Poviztra 1mg FlexTouch is a once-weekly injection containing semaglutide, a GLP-1 receptor agonist that mimics a natural hormone regulating appetite and food intake. It is indicated for weight management in adults. The medication works by helping patients feel full sooner and maintain satiety longer, supporting reduced caloric intake and healthier dietary choices.
Patients using Poviztra 0.5mg alongside a balanced diet and regular physical activity commonly experience gradual and sustained weight reduction, with improved hunger and craving control. Weight loss with this medication is not rapid but represents a supportive therapy within a long-term weight management framework.
Poviztra 1mg FlexTouch is recommended for patients who are overweight or living with obesity, particularly those with concurrent conditions such as elevated blood pressure, type 2 diabetes, or high cholesterol. Treatment forms part of a comprehensive weight management plan incorporating dietary modification and regular physical activity.
Assessment by a doctor is necessary before starting treatment. Your doctor will review your medical history to determine whether Poviztra 1mg FlexTouch is appropriate for your weight management needs.
Uses
Poviztra 1mg FlexTouch is approved for: Long-term weight management in adults with obesity (BMI of 30 or more) Weight management in adults with a BMI of 27 or more who also have weight-related health issues like type 2 diabetes, high blood pressure, or high cholesterol
How it works
Poviztra 1mg FlexTouch supports weight loss by mimicking natural hormones that regulate hunger. As a GLP-1 medication, it sends signals to your brain that you are full, helping you feel satisfied after smaller meals. It also slows down the movement of food through your stomach, which prolongs fullness and reduces cravings. Poviztra 1mg FlexTouch influences GIP, another hormone involved in metabolism, which can help improve how your body handles nutrients and supports weight management. Using a GLP-based approach like Poviztra 1mg FlexTouch provides consistent appetite control over time. Results appear gradually, allowing you to eat less without feeling deprived, which is essential for sustainable, long-term weight loss.
Side Effects
Poviztra 1mg FlexTouch causes some side effects like all medications, although not everyone will experience them. Common side effects: Nausea Vomiting Constipation or diarrhoea Tiredness Headache Indigestion Bloating or gas Serious side effects (get medical help if you notice these): Severe stomach pain or signs of pancreatitis Gallbladder issues (like pain in your upper belly or yellowing of the skin) Signs of kidney problems (such as less urination or swelling) Fast heart rate Allergic reactions (rash, itching, swelling, trouble breathing)
References
- Novo Nordisk Inc, FDA Food and Drug Safety Administration [September 20, 2019] [Accessed date 18th August 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209637s032lbl.pdf
- Novo Nordisk Limited, EMC, [25 Jan 2023], [Accessed date 18th August 2023] Electronic Medicines Compendium (EMC), [Revised on 25th Jan 2023] [Accessed on 18 August 2023] https://www.ema.europa.eu/en/documents/overview/ozempic-epar-summary-public_en.pdf
- https://cdscoonline.gov.in/CDSCO/cdscoDrugs
Safety Advice
Pregnancy: Unsafe Poviztra 1mg FlexTouch is not safe during pregnancy. If you're planning to get pregnant, you'll need to stop this medication at least 2 months before trying.
Lungs: Consult Your Doctor Poviztra 1mg FlexTouch doesnât directly affect your lungs. If you have asthma or another lung issue, itâs still safe, but your doctor should be in the loop.
Breastfeeding: Consult Your Doctor If you are breastfeeding, consult your healthcare provider before using Poviztra 1mg FlexTouch, as its efficacy and safety in breastfeeding are unknown.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.